Essa Pharma Inc (id:5569 EPIX)
1.83 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 11:44:21 AM)
Exchange closed, opens in 1 day 21 hours
5.17 USD (5.17%)
6.40 USD (6.40%)
-69.75 USD (-69.75%)
-71.18 USD (-71.18%)
-69.45 USD (-69.45%)
-63.25 USD (-63.25%)
-97.86 USD (-97.86%)
About Essa Pharma Inc
Market Capitalization 81.23M
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
| Headquarters (address) |
999 West Broadway Vancouver V5Z 1K5 BC Canada |
| Phone | 778 331 0962 |
| Website | https://www.essapharma.com |
| Employees | 50 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | EPIX |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.40 - 11.67 |
| Market Capitalization | 81.23M |
| P/E trailing | -3.05 |
| P/E forward | -3.66 |
| Price/Book | 0.630 |
| Beta | 1.84 |
| EPS | -0.620 |
| EPS Canada (ID:82, base:722) | 1.84 |